Concourse Financial Group Securities’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-601
| Closed | -$23.1K | – | 5165 |
|
|
2024
Q4 | $23.1K | Sell |
601
-49
| -8% | -$1.89K | ﹤0.01% | 1505 |
|
|
2024
Q3 | $43.4K | Sell |
650
-151
| -19% | -$10.1K | ﹤0.01% | 1234 |
|
|
2024
Q2 | $95.1K | Buy |
801
+2
| +0.3% | +$237 | 0.01% | 945 |
|
|
2024
Q1 | $85.1K | Buy |
799
+25
| +3% | +$2.66K | 0.01% | 975 |
|
|
2023
Q4 | $77K | Sell |
774
-20
| -3% | -$1.99K | 0.01% | 985 |
|
|
2023
Q3 | $82K | Sell |
794
-136
| -15% | -$14K | 0.01% | 912 |
|
|
2023
Q2 | $113K | Buy |
930
+176
| +23% | +$21.4K | 0.01% | 842 |
|
|
2023
Q1 | $116K | Sell |
754
-66
| -8% | -$10.1K | 0.01% | 824 |
|
|
2022
Q4 | $147K | Sell |
820
-9
| -1% | -$1.62K | 0.01% | 705 |
|
|
2022
Q3 | $98K | Buy |
829
+334
| +67% | +$39.5K | 0.01% | 729 |
|
|
2022
Q2 | $71K | Sell |
495
-52
| -10% | -$7.46K | 0.01% | 941 |
|
|
2022
Q1 | $94K | Sell |
547
-454
| -45% | -$78K | 0.01% | 889 |
|
|
2021
Q4 | $254K | Sell |
1,001
-58
| -5% | -$14.7K | 0.01% | 651 |
|
|
2021
Q3 | $408K | Sell |
1,059
-233
| -18% | -$89.8K | 0.02% | 510 |
|
|
2021
Q2 | $303K | Buy |
1,292
+136
| +12% | +$31.9K | 0.02% | 588 |
|
|
2021
Q1 | $151K | Buy |
1,156
+24
| +2% | +$3.14K | 0.01% | 770 |
|
|
2020
Q4 | $118K | Buy |
1,132
+397
| +54% | +$41.4K | 0.01% | 815 |
|
|
2020
Q3 | $52K | Buy |
735
+143
| +24% | +$10.1K | ﹤0.01% | 1044 |
|
|
2020
Q2 | $38K | Buy |
+592
| New | +$38K | ﹤0.01% | 1075 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4392 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4333 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4118 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4320 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4257 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4139 |
|